📉 🔻
🔹 Asset: Keros Therapeutics, Inc. (KROS – NASDAQ)
🔹 Chart Pattern: Rising Wedge Breakdown + Lower High Rejection
🔹 Timeframe: 30-Minute
📊 Trade Plan – Short Position
✅ Entry Zone: $14.29 (Breakdown + yellow zone rejection + trendline failure)
✅ Stop-Loss (SL): $14.69 (Above recent high + wedge resistance)
🎯 Take Profit Targets:
📌 TP1: $13.57 – Key support zone
📌 TP2: $12.89 – Strong demand base & trend origin
📐 Risk-Reward Calculation
🟥 Risk per share: $0.40
🟩 Reward to TP2: $1.40
📊 R/R Ratio: ~1 : 3.5 – Excellent setup for swing short
🔍 Technical Highlights
📌 Breakdown of rising wedge pattern confirmed
📌 Yellow zone flipped to resistance ✔
📌 Strong rejection candle near wedge top
📌 Increasing selling pressure with volume divergence
📉 Risk Management Strategy
🔁 Shift SL to breakeven after TP1 hit
💰 Secure partial profits at $13.57
🚀 Let the runner ride to $12.89 with a trailing stop
🚨 Setup Invalidation If:
❌ Price reclaims $14.69 and closes above
❌ Bullish engulfing near wedge resistance
❌ Lack of follow-through or volume drying up
🔹 Asset: Keros Therapeutics, Inc. (KROS – NASDAQ)
🔹 Chart Pattern: Rising Wedge Breakdown + Lower High Rejection
🔹 Timeframe: 30-Minute
📊 Trade Plan – Short Position
✅ Entry Zone: $14.29 (Breakdown + yellow zone rejection + trendline failure)
✅ Stop-Loss (SL): $14.69 (Above recent high + wedge resistance)
🎯 Take Profit Targets:
📌 TP1: $13.57 – Key support zone
📌 TP2: $12.89 – Strong demand base & trend origin
📐 Risk-Reward Calculation
🟥 Risk per share: $0.40
🟩 Reward to TP2: $1.40
📊 R/R Ratio: ~1 : 3.5 – Excellent setup for swing short
🔍 Technical Highlights
📌 Breakdown of rising wedge pattern confirmed
📌 Yellow zone flipped to resistance ✔
📌 Strong rejection candle near wedge top
📌 Increasing selling pressure with volume divergence
📉 Risk Management Strategy
🔁 Shift SL to breakeven after TP1 hit
💰 Secure partial profits at $13.57
🚀 Let the runner ride to $12.89 with a trailing stop
🚨 Setup Invalidation If:
❌ Price reclaims $14.69 and closes above
❌ Bullish engulfing near wedge resistance
❌ Lack of follow-through or volume drying up
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.